|[June 20, 2014]
PixarBio Expands Board of Directors to Prepare for Future Growth
MEDFORD, Mass. --(Business Wire)--
PixarBio Corporation today announced two new members of the Board of
Directors. David Cass will serve as an independent member and he'll join
the audit committee as well as the governance and nominating committee.
Katrin Holzhaus will join the Board of Directors and serve as Secretary
of the Board. In addition, Katrin will be a member of the governance and
PixarBio CEO Frank Reynolds said, "We've added two key members to our
Board of Directors, in order to establish the necessary credibility and
integrity, for a strong shareholder value-driven corporate governance
model. We'll quickly work to become and then remain SEC (News - Alert) compliant to be
a fully reporting company. We're entering our next important phase of
development as we accelerate our growth plans from Q3 2014 through Q4
2015. We expect to be approved to begin human studies in multiple orphan
status neurological conditions in 2016. If luck does favor the prepared
mind, then we've had an incredibly lucky first year in our PixarBio
Mr. Cass is the Chief Information Security Officer for Elsevier.
Elsevier publishes more than 2,000 journals and 20,000 books. They are a
world-leading provider of information solutions that enhance the
performance of science, health, and technology professionals, empowering
them to make better decisions, deliver better care, and sometimes make
groundbreaking discoveries. He leads an organization of experienced
legal, risk and security professionals that provide data protection,
privacy, security, and risk management guidance on a global basis for
David has extensive experience in IT security, risk assessment, risk
management, business continuity and disaster recovery, developing
security policies and procedures. He has played a key role in leading
and building corporate risk & governance and information security
organizations in the financial sector. As the Senior Director of
Information Security Risk and Governance for Freddie Mac, David rebuilt
the risk and governance function and developed a team to provide risk
assessments, methodologies, tools, services, and training to improve the
maturity and capabilities of Freddie Mac's information security, risk
and governance programs. Prior to that he was Vice President of Risk
Management for JPMorgan Chase, and was responsible for providing an
accurate assessment of the current risk management state, contributing
to the future direction of risk management, continuity and disaster
recovery capabilities for the organization. David's MBA is from The
MIT (News - Alert)-Sloan School of Business, and he received his Masters of Science in
Engineering from Penn Engineering and The Wharton School. David is a
Coast Guard licensed Captain and a volunteer firefighter. David married
his college sweetheart Julie, and has one daughter Samantha.
"I've had the opportunity to meet with the PixarBio team, and it is
clear that Mr. Reynolds has assembled a strong team of dedicated and
accomplished professionals. I look forward to serving on both the audit
and the governance and nominating committees and to being a member of
the Board of Directors."
"I met David as a peer at The Wharton School and I've observed David
lead his business units at JP Morgan (News - Alert) Chase, and Freddie Mac," said Frank
Reynolds. "Now at Elsevier, David has an established track record with
the utmost integrity, credibility, and professionalism". David will
serve as a member of the audit and general nominations committee.
Katrin Holzhaus cofounded PixarBio as Chief Operating Officer,
leveraging her 20 years of experience as entrepreneur and leader in
operations, development, and global marketing. Having worked closely
with cofounder Frank Reynolds for more than 14 years initially at Expand
the Knowledge, and then with InVivo Therapeutics Holdings Corp (NVIV),
Ms. Holzhaus brings complimentary leadership skillsets to PixarBio's
operations team and a proven record of success. Most recently, she held
executive positions at InVivo Therapeutics, a developer of
groundbreaking technologies for the treatment of spinal cord injuries.
From 2004-2012, she was Director of Operations at Magnum Group, Inc., a
leading global linguistic consulting company.
"Katrin has been on the front edge of innovative decision making for a
long time and brings unique skills to every project she leads for
PixarBio. She'll serve as the Secretary of the Board, and as a member of
The Board's general nominating committee, Katrin will ensure shareholder
assets are focused on shareholder value creating initiatives", says
Frank Reynolds. "With our new state-of-the-art chem lab, tissue lab, and
bio labs up and running, our expanding team of industry-leading experts
is creating value every day. As we plan clinical pathways to market for
four fields of medicine, PixarBio is entering an important new phase of
development. It is an exciting time to join the company's Board of
Directors and I am thrilled to be part of this outstanding team,"
continues Katrin Holzhaus.
Katrin Holzhaus received her MBA and MS in Management Information
Systems from Temple University, Philadelphia, Pennsylvania and a Master
of Arts in Linguistics from Leipzig University, Germany.
About PixarBio Corporation
PixarBio Corporation is dedicated to developing new therapeutic options
for Parkinson's disease, epilepsy, pain, and spinal cord injury.
Cofounded by Frank Reynolds, Dr. Robert S. Langer from MIT's Langer Lab,
Dr. Randy Holmes-Farley, and Katrin Holzhaus the company is developing
novel smart materials to achieve sustained release of agents. Research
is focused on a platform for chronic neurological applications. For more
information visit www.pixarbio.com.
[ Back To TMCnet.com's Homepage ]